GLP-1 weight-loss drugs show early signs of slowing biological aging in patients.

#Weightloss #drugs show signs of slowing biological #aging, say drugmakers #NovoNordisk and #EliLilly found the popular medicines reduce molecular markers of age. Both companies found that overweight or diabetic patients taking the drugs, called #GLP1, had reduced biological #age compared to those taking a placebo, although the difference varied widely, depending on which type of clock was used, and what organ was tested. https://www.technologyreview.com/2026/10/06/1145836/weight-loss-drugs-glp1-lilly-novo-aging-clocks/ https://archive.ph/0ZKpB

Weight-loss drugs show signs of slowing biological aging, say drugmakers https://www.technologyreview.com/2026/10/06/1145836/weight-loss-drugs-glp1-lilly-novo-aging-clocks/ #biology #medicine

Weight-loss drugs may slow biological aging: Eli Lilly and Novo Nordisk report early signs from GLP-1 patient data https://www.technologyreview.com/2026/10/06/1145836/weight-loss-drugs-glp1-lilly-novo-aging-clocks/ Popular weight-loss drugs may do more than help people shed pounds. They might also melt away the years. Drug giants Eli Lilly and Novo Nordisk say patients taking their drugs age less quickly,… #mix #health #pharma

Weight-loss drugs may slow biological aging: Eli Lilly and Novo Nordisk report early signs from GLP-1 patient data https://www.technologyreview.com/2026/10/06/1145836/weight-loss-drugs-glp1-lilly-novo-aging-clocks/ #mix #health #pharma